+86-28-82633987
ISO ISO
ISO 17025 ISO 17025
usp usp
EN
CN EN

Spiraeoside

BP1337
20229-56-5
98%
普瑞法
Spiraeoside has antioxidant, anti-inflammatory, ulcer preventive and gastroprotective activities, it inhibits mast cells activation and IgE-mediated allergic responses by suppressing phospholipase C-γ-mediated signaling. Spiraeoside shows anti-plasmin activity, which is considered to play a key role in UV-stimulated melanogenesis in human skin. Spiraeoside is a new inhibitor of the DENV-NS5 RdRp from Carpolepis laurifolia as a potential antiviral drug for dengue treatment. Quercetin 4'-O-beta-D-glucopyranoside is a quercetin O-glucoside that is quercetin with a beta-D-glucosyl residue attached at position 4'. It has a role as an antioxidant, an antineoplastic agent and a plant metabolite. It is a beta-D-glucoside, a member of flavonols, a tetrahydroxyflavone, a monosaccharide derivative and a quercetin O-glucoside. It is functionally related to a beta-D-glucose. It is a conjugate acid of a quercetin 4'-O-beta-D-glucopyranoside(1-).
Catalog No Package Original Price Price Inventory Quantity Operating
BP1337-5mg 5mg
BP1337-10mg 10mg
BP1337-20mg 20mg
BP1337-100mg 100mg
Chengdu Biopurify Phytochemicals Ltd.
Chengdu Biopurify Phytochemicals Ltd.

Related targets

TNF PTGS2 NFKB1 IL6 IL1B
TNF PTGS2 NFKB1 HRH1 IL4

Product drug property prediction parameters

  • 210.5100

  • -.1494

  • -.4768

  • 1.4769

  • .5631

  • .0715

  • Low

  • 78.7153

  • 4.0314

  • Yes

  • No

  • No

  • No

  • Yes

  • No

  • 0.6

  • Yes

  • No

  • Yes

  • No